[PDF][PDF] IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

S Grivennikov, E Karin, J Terzic, D Mucida, GY Yu… - Cancer cell, 2009 - cell.com
S Grivennikov, E Karin, J Terzic, D Mucida, GY Yu, S Vallabhapurapu, J Scheller…
Cancer cell, 2009cell.com
Colitis-associated cancer (CAC) is the most serious complication of inflammatory bowel
disease. Proinflammatory cytokines have been suggested to regulate preneoplastic growth
during CAC tumorigenesis. Interleukin 6 (IL-6) is a multifunctional NF-κB-regulated cytokine
that acts on epithelial and immune cells. Using genetic tools, we now demonstrate that IL-6
is a critical tumor promoter during early CAC tumorigenesis. In addition to enhancing
proliferation of tumor-initiating cells, IL-6 produced by lamina propria myeloid cells protects …
Summary
Colitis-associated cancer (CAC) is the most serious complication of inflammatory bowel disease. Proinflammatory cytokines have been suggested to regulate preneoplastic growth during CAC tumorigenesis. Interleukin 6 (IL-6) is a multifunctional NF-κB-regulated cytokine that acts on epithelial and immune cells. Using genetic tools, we now demonstrate that IL-6 is a critical tumor promoter during early CAC tumorigenesis. In addition to enhancing proliferation of tumor-initiating cells, IL-6 produced by lamina propria myeloid cells protects normal and premalignant intestinal epithelial cells (IECs) from apoptosis. The proliferative and survival effects of IL-6 are largely mediated by the transcription factor Stat3, whose IEC-specific ablation has profound impact on CAC tumorigenesis. Thus, the NF-κB-IL-6-Stat3 cascade is an important regulator of the proliferation and survival of tumor-initiating IECs.
cell.com